Heliospectra’s Incentive Program Transfer Stock Warrants to Senior Executives and Key Personnel

Report this content

Heliospectra AB (publ) ("the Company") has through the wholly owned subsidary Heliospectra Personal AB ("the Subsidiary") today executed the transfer of 905,000 stock warrants of series P02 from the Company to a total of 25 senior executives and / or key personnel within the group. The stock warrants were originally issued to the Subsidiary at the Company’s Extra Ordinary General Meeting held on March 12, 2019. 

In accordance with the terms of the stock warrants, the Company has established the market value of the warrants per transfer day in accordance with the Black & Scholes option valuation model and the principles of the issue decision. The market value has been set at SEK 0.34 per option. The subscription price for the warrants has been set at SEK 6.13 per share and has been calculated in accordance with the principles of the issue resolution.

The subsidiary still holds the remaining 95,000 stock warrants of series P02 which in future may be offered to senior executives and key personnel.

Investor Relations:

Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 | ir@heliospectra.com

Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
Certifiedadviser@redeye.se | +46 (0)8 121 576 90

http://www.heliospectra.com

Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the global leader in intelligent lighting technology, light control systems and related services for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, Heliospectra integrates customized LED spectral strategies with real-time response and artificial intelligence to create predictable and reliable business forecasts and harvest results. Founded in 2006, Heliospectra is committed to helping growers and commercial producers across six continents consistently increase yields and produce crops with quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Heliospectra is the recipient of multiple international awards and recognitions. For more information, please visit https://www.heliospectra.com.  

Forward-Looking Statements

The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

This information was submitted for publication, through the agency of the contact person set out above, at 15:00 CEST / 8 AM CDT on April 18 th 2019.

Tags:

Subscribe

Documents & Links